Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Kriya Therapeutics raises $313.3 funding

(Image credit: ©Hand Robot/AdobeStock) Kriya Therapeutics reported in an SEC filing it has raised $313.3 million in a recent funding round.1 The filing does not detail fund specificity or funding sources but rather only states two investors participated in the…

Racial and ethnic disparities in retinoblastoma treatment options

Vivienne S. Hau, MD, PhD, a vitreoretinal surgeon and faculty member at the Bernard J Tyson School of Medicine, Kaiser Permanente Med School, and also at the California University of School of Medicine, presented research on racial and ethnic disparities…

Dropless vitrectomy with suprachoroidal triamcinolone-moxifloxacin

(Image credit: AdobeStock/Drazen) K. Chalam MD, PhD, MBA, FRCS(C), FASRS, presented, “Dropless vitrectomy with suprachoroidal triamcinolone-moxifloxacin: A comparative analysis of safety and efficacy with standard-of-care topical drops” at the 2025 annual scientific meeting of the American Society of Retina Specialists.…

Cannula vs needle in tear trough treatment

(Image Credit: AdobeStock/ME Image) Tear trough filler remains a topic of debate among some surgeons due to concerns about complications such as edema, malar mound accentuation, and vascular compromise. Nonetheless, this treatment has continuously proven to be an effective tool…

Stay informed and not overwhelmed, subscribe now!